Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Cytomx Therapeutics, Inc. (CTMX)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 65,160,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   CytomX Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company. Co. is developing an antibody-based therapeutics created using its Probody® therapeutic technology platform. Co.'s products include: Praluzatamab ravtansine, which is an activated antibody-drug conjugates directed against CD166, a tumor target previously considered undruggable due to its high expression on normal tissues; CX-2029, which opens a therapeutic window for targeting CD71; Pacmilimab, which is a Probody therapeutic against PD-L1, a clinically and commercially validated cancer target; and BMS-986249 and BMS-986288, which is the Probody versions of ipilimumab.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 47,819 75,591 103,916 162,805
Total Sell Value $99,726 $138,068 $174,902 $267,502
Total People Sold 5 5 5 8
Total Sell Transactions 5 10 14 26
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 286
  Page 12 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Gluck Frederick W Director   –       •      –    2015-10-14 4 B $12.00 $60,000 I/I 5,000 5,000 2.1     -
   Gluck Frederick W Director   –       •      –    2015-10-14 4 B $12.00 $120,000 D/D 10,000 147,791 2.39     -
   Ladd Cynthia J Senior VP and General Counsel   •       –      –    2015-10-14 4 B $12.00 $36,000 D/D 3,000 3,000 2.74     -
   Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev.   •       –      –    2015-10-14 4 B $12.00 $60,000 D/D 5,000 5,000 2.74     -
   Shannon Timothy M Director   –       •      –    2015-10-14 4 A $0.00 $0 I/I 4,884,755 1,318,418     -
   Hadley Harbor Master Investors (cayman) L.p. 10% Owner   –       –       •   2015-10-14 4 A $0.00 $0 D/D 749,055 749,055     -
   Deerfield Private Design Fund Iii, L.p. Possible Member of 10% Group   –       –       •   2015-10-14 4 B $12.00 $7,500,000 I/I 625,000 275,000 1.5     -
   Deerfield Private Design Fund Iii, L.p. Possible Member of 10% Group   –       –       •   2015-10-14 4 A $0.00 $0 I/I 321,024 160,512     -
   Gluck Frederick W Director   –       •      –    2015-10-07 3 IO $0.00 $0 I/I 0 3,200     -
   Gluck Frederick W Director   –       •      –    2015-10-07 3 IO $0.00 $0 D/D 0 137,791     -
   Mccarthy Sean A. President and CEOOfficer   •       •      –    2015-10-07 3 IO $0.00 $0 I/I 0 158,737     -

  286 Records found
  Previous  10  11  12    
  Page 12 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed